Safe re-initiation of infliximab in a patient with renal tuberculosis.
Kemta Lekpa
F
F
Marini-Portugal
A
A
Lesprit
P
P
Chevalier
X
X
Claudepierre
P
P
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D000075202:Contraindications; D006801:Humans; D000069285:Infliximab; D008297:Male; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D014398:Tuberculosis, Renal / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D028761:Withholding Treatment
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D000069285:Infliximab